Please try another search
For the fiscal year ended 31 December 2020, Farmak AT revenues increased 15% to UAH7.52B. Net income before extraordinary items increased 7% to UAH1.15B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Foreign Exchange Gain/Loss increase from UAH0K to UAH126.4M (expense).
Period Ending: | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 7515.34 | 6541.75 | 6618.91 | 6084.68 |
Gross Profit | 4190.71 | 3714.91 | 3685.14 | 3361.02 |
Operating Income | 1548.02 | 1232.77 | 1360.1 | 1190.11 |
Net Income | 1149.7 | 1056.97 | 1050.23 | 838.87 |
Period Ending: | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 8427.55 | 6644.1 | 5928.98 | 4859.72 |
Total Liabilities | 2158.37 | 1424.86 | 1645.72 | 1483.99 |
Total Equity | 6269.18 | 5219.24 | 4283.26 | 3375.73 |
Period Ending: | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | 2401.39 | 858.04 | 836.38 | 1007.57 |
Cash From Investing Activities | -1244.48 | -620.6 | -632.96 | -487.62 |
Cash From Financing Activities | -90.23 | -181.33 | -146.76 | -511.31 |
Net Change in Cash | 1090.87 | 55.52 | 56.02 | 9.93 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review